DK1020462T3 - Heterocykliske forbindelser og antitumormiddel indeholdende disse som aktiv ingrediens - Google Patents
Heterocykliske forbindelser og antitumormiddel indeholdende disse som aktiv ingrediensInfo
- Publication number
- DK1020462T3 DK1020462T3 DK98933922T DK98933922T DK1020462T3 DK 1020462 T3 DK1020462 T3 DK 1020462T3 DK 98933922 T DK98933922 T DK 98933922T DK 98933922 T DK98933922 T DK 98933922T DK 1020462 T3 DK1020462 T3 DK 1020462T3
- Authority
- DK
- Denmark
- Prior art keywords
- active ingredient
- heterocyclic compounds
- agents containing
- tumor agents
- tumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19880497 | 1997-07-24 | ||
PCT/JP1998/003308 WO1999005138A1 (fr) | 1997-07-24 | 1998-07-24 | Composes heterocycliques et agent antitumoral contenant lesdits composes utilises comme ingredients actifs |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1020462T3 true DK1020462T3 (da) | 2004-04-26 |
Family
ID=16397198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98933922T DK1020462T3 (da) | 1997-07-24 | 1998-07-24 | Heterocykliske forbindelser og antitumormiddel indeholdende disse som aktiv ingrediens |
Country Status (11)
Country | Link |
---|---|
US (1) | US6251900B1 (de) |
EP (1) | EP1020462B1 (de) |
JP (1) | JP4276376B2 (de) |
KR (1) | KR100563514B1 (de) |
CN (1) | CN1129597C (de) |
AU (1) | AU727013B2 (de) |
CA (1) | CA2297326C (de) |
DE (1) | DE69821633T2 (de) |
DK (1) | DK1020462T3 (de) |
ES (1) | ES2213286T3 (de) |
WO (1) | WO1999005138A1 (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000029404A1 (fr) | 1998-11-17 | 2000-05-25 | Kumiai Chemical Industry Co., Ltd. | Derives de pyrimidinylbenzimidazole et de triazinylbenzimidazole et bactericides agricoles/horticoles |
JP4709388B2 (ja) * | 1999-01-25 | 2011-06-22 | 全薬工業株式会社 | 複素環式化合物及びそれを有効成分とする抗腫瘍剤 |
US6989379B1 (en) | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
US6340683B1 (en) * | 1999-04-22 | 2002-01-22 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (triazines) |
PT1183245E (pt) * | 1999-04-22 | 2007-07-12 | Lundbeck & Co As H | Antagonistas selectivos de npy (y5) |
US6218408B1 (en) | 1999-06-30 | 2001-04-17 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
US7273880B2 (en) | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
US6225330B1 (en) | 1999-06-30 | 2001-05-01 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
US6222040B1 (en) | 1999-06-30 | 2001-04-24 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
US6214853B1 (en) | 1999-06-30 | 2001-04-10 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
US6943161B2 (en) * | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
DE60217322T2 (de) * | 2001-04-27 | 2007-10-04 | Zenyaku Kogyo K.K. | Heterocyclische verbindung und antitumormittel, das diese als wirkstoff enthält |
JP4493503B2 (ja) * | 2002-10-25 | 2010-06-30 | 全薬工業株式会社 | 複素環式化合物及びそれを有効成分とする抗腫瘍剤 |
EP2316831B1 (de) * | 2002-11-21 | 2013-03-06 | Novartis AG | 2-(morpholin-4-yl)Pyrimidinen als Phosphotidylinositol (PI) 3-Kinase Inhibitoren und deren Verwendung zur Behandlung von Krebs |
US20050107374A1 (en) * | 2003-10-21 | 2005-05-19 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
DK1741714T3 (da) * | 2004-03-31 | 2013-04-15 | Zenyaku Kogyo Kk | Heterocyklisk forbindelse og middel mod ondartet turmor, der indeholder denne som aktiv ingrediens |
EP1796673A2 (de) * | 2004-09-23 | 2007-06-20 | Reddy US Therapeutics, Inc. | Neue pyrimidin-verbindungen, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen |
CA2599879C (en) * | 2005-03-11 | 2013-07-02 | Zenyaku Kogyo Kabushikikaisha | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
JO2660B1 (en) * | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
US20070244110A1 (en) * | 2006-04-14 | 2007-10-18 | Zenyaku Kogyo Kabushiki Kaisha | Treatment of prostate cancer, melanoma or hepatic cancer |
WO2008032041A1 (en) * | 2006-09-14 | 2008-03-20 | Astrazeneca Ab | Pyrimidine derivatives having inhibitory activity against pi3k enzymes |
WO2008032091A1 (en) * | 2006-09-14 | 2008-03-20 | Astrazeneca Ab | 4-benzimidaz0lyl-6-m0rph0lin0-2-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
WO2008032036A1 (en) * | 2006-09-14 | 2008-03-20 | Astrazeneca Ab | 6-benzimidaz0lyl-2-m0rph0lin0-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
WO2008032089A1 (en) * | 2006-09-14 | 2008-03-20 | Astrazeneca Ab | 4-benzimidaz0lyl-2-m0rph0lin0-6-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
US20090270390A1 (en) * | 2006-09-14 | 2009-10-29 | Astrazeneca | Pyrimidine derivatives |
WO2008032033A1 (en) * | 2006-09-14 | 2008-03-20 | Astrazeneca Ab | 4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
WO2008032072A1 (en) * | 2006-09-14 | 2008-03-20 | Astrazeneca Ab | 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
WO2008098058A1 (en) * | 2007-02-06 | 2008-08-14 | Novartis Ag | Pi 3-kinase inhibitors and methods of their use |
WO2008147540A1 (en) * | 2007-05-23 | 2008-12-04 | New York University School Of Medicine | S-triazine compounds, pharmaceutical compositions and methods of using the same |
PT2409975E (pt) | 2007-11-22 | 2015-07-27 | Zenyaku Kogyo Kk | Dispersões sólidas compreendendo um corpo amorfo composto por um composto antitumoral heterocíclico |
JP2011515462A (ja) * | 2008-03-27 | 2011-05-19 | アウククランド ウニセルビセス リミテッド | 置換されたピリミジン、及びトリアジン、並びに癌療法におけるこれらの使用 |
US10022381B2 (en) | 2008-05-23 | 2018-07-17 | Pfizer Inc. | Triazine compounds as PI3 kinase and mTOR inhibitors |
WO2009143317A1 (en) * | 2008-05-23 | 2009-11-26 | Wyeth | Triazine compounds as p13 kinase and mtor inhibitors |
WO2010012745A2 (en) * | 2008-07-29 | 2010-02-04 | Boehringer Ingelheim International Gmbh | Benzimidazoles |
KR20110120286A (ko) | 2009-02-12 | 2011-11-03 | 아스텔라스세이야쿠 가부시키가이샤 | 헤테로환 유도체 |
WO2010096619A1 (en) * | 2009-02-23 | 2010-08-26 | Wyeth Llc | Process, purification and crystallization of 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea |
CA2756067A1 (en) | 2009-03-27 | 2010-09-30 | Pathway Therapeutics, Inc. | Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
EP2451802A1 (de) * | 2009-07-07 | 2012-05-16 | Pathway Therapeutics, Inc. | Pyrimidinyl- und 1,3,5-triazinyl-benzimidazole und ihre verwendung in der krebstherapie |
GB201007227D0 (en) | 2010-04-30 | 2010-06-16 | Univ Basel | Piperazinotriazines |
JP5765342B2 (ja) | 2010-08-10 | 2015-08-19 | アステラス製薬株式会社 | へテロ環化合物 |
WO2012135160A1 (en) | 2011-03-28 | 2012-10-04 | Pathway Therapeutics Inc. | (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases |
AU2012313888B2 (en) | 2011-09-27 | 2016-03-31 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
UY34632A (es) | 2012-02-24 | 2013-05-31 | Novartis Ag | Compuestos de oxazolidin- 2- ona y usos de los mismos |
WO2014055647A1 (en) * | 2012-10-03 | 2014-04-10 | Mei Pharma, Inc. | (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases |
US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
WO2014090147A1 (zh) * | 2012-12-14 | 2014-06-19 | 上海恒瑞医药有限公司 | 嘧啶类衍生物及其可药用盐、其制备方法及其在医药上的应用 |
AP2015008707A0 (en) | 2013-03-14 | 2015-09-30 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
CN105175410B (zh) * | 2015-10-14 | 2018-01-05 | 湖南华腾制药有限公司 | 三嗪类化合物及其制备方法和抗肿瘤应用 |
MX2019013862A (es) | 2017-05-23 | 2020-01-20 | Mei Pharma Inc | Terapia de combinacion. |
CA3072476A1 (en) | 2017-08-14 | 2019-02-21 | Mei Pharma, Inc. | Combination therapy |
EP3967694A4 (de) * | 2019-06-06 | 2022-12-07 | Beijing Tide Pharmaceutical Co., Ltd. | 2, 4, 6-tri-substituierte pyrimidinverbindung als atr-kinase-inhibitor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0948776A (ja) * | 1994-09-26 | 1997-02-18 | Dai Ichi Seiyaku Co Ltd | ピリミジニルピラゾール誘導体 |
-
1998
- 1998-07-24 EP EP98933922A patent/EP1020462B1/de not_active Expired - Lifetime
- 1998-07-24 DE DE69821633T patent/DE69821633T2/de not_active Expired - Lifetime
- 1998-07-24 US US09/463,214 patent/US6251900B1/en not_active Expired - Lifetime
- 1998-07-24 DK DK98933922T patent/DK1020462T3/da active
- 1998-07-24 CA CA002297326A patent/CA2297326C/en not_active Expired - Fee Related
- 1998-07-24 AU AU83575/98A patent/AU727013B2/en not_active Ceased
- 1998-07-24 WO PCT/JP1998/003308 patent/WO1999005138A1/ja active IP Right Grant
- 1998-07-24 ES ES98933922T patent/ES2213286T3/es not_active Expired - Lifetime
- 1998-07-24 KR KR1020007000424A patent/KR100563514B1/ko not_active IP Right Cessation
- 1998-07-24 CN CN98809385A patent/CN1129597C/zh not_active Expired - Fee Related
- 1998-07-24 JP JP2000504134A patent/JP4276376B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1020462A4 (de) | 2003-01-08 |
CN1129597C (zh) | 2003-12-03 |
ES2213286T3 (es) | 2004-08-16 |
WO1999005138A1 (fr) | 1999-02-04 |
KR20010021860A (ko) | 2001-03-15 |
EP1020462B1 (de) | 2004-02-11 |
CA2297326A1 (en) | 1999-02-04 |
CN1271355A (zh) | 2000-10-25 |
JP4276376B2 (ja) | 2009-06-10 |
EP1020462A1 (de) | 2000-07-19 |
KR100563514B1 (ko) | 2006-03-27 |
AU727013B2 (en) | 2000-11-30 |
DE69821633D1 (de) | 2004-03-18 |
US6251900B1 (en) | 2001-06-26 |
AU8357598A (en) | 1999-02-16 |
DE69821633T2 (de) | 2004-12-16 |
CA2297326C (en) | 2007-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1020462T3 (da) | Heterocykliske forbindelser og antitumormiddel indeholdende disse som aktiv ingrediens | |
NO993868D0 (no) | 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike | |
IS5058A (is) | Samverkandi súlfónýlþvagefnis-glitasónsblöndur við sykursýki | |
NO20001631L (no) | 2-metyl-tieno-benzodiazepin formulering | |
DK1028961T5 (da) | Pleuromutilinderivater som antimikrobielle midler | |
ID22878A (id) | Komposisi aktif secara terapi | |
NO20000048L (no) | Triazolforbindelser og deres anvendelse som dopamin-D3- ligander | |
DK1062217T3 (da) | Herbicidt aktive 3-hydroxy-4-aryl-5-oxopyrazolinderivater | |
NO20021401D0 (no) | Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser | |
DK1001813T3 (da) | Farmaceutiske formuleringer indeholdende voriconazol | |
NO980546D0 (no) | Farmasöytiske midler | |
NO982296L (no) | Triaromatiske forbindelser, preparater inneholdende disse og deres anvendelse | |
DE69823360D1 (de) | Feste arzneizubereitung enthaltend benzofuranderivate | |
NO984106D0 (no) | Azolobenzazepin-derivater som neurologisk aktive midler | |
NO308294B1 (no) | Dimetyl-3(aryl-but-3-enyl)-aminforbindelse som farmasøytiske forbindelser og anvendelse av disse | |
NO996584D0 (no) | brukshjelp for absorberende gjenstand til engangsbruk | |
ATE218540T1 (de) | Mikrobiozide n-sulfonylglycin- alkynyloxyphenethylamid-derivate | |
NO981121L (no) | Substituerte aminoforbindelser og deres anvendelse som analgetisk virksomme stoffer | |
NO20006646D0 (no) | Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel | |
NO20000366D0 (no) | O-substituerte hydroksycoumaranon-derivater som anti-tumor- og antimetastase-midler | |
NO20013318L (no) | Substituerte 2-aryliminoheterocykliske forbindelser og preparater inneholdende disse for anvendelse | |
NO973471D0 (no) | Transdermal formulering | |
DK0868911T3 (da) | Rapamycinpræparater til oral indgivelse | |
NO973715D0 (no) | Transdermal formulering | |
ID18793A (id) | Bahan penahan untuk pestisida |